Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-World Research of Treatment Patterns and Treatment Adherence in Early HER2-positive Breast Cancer in Serbia After Treatment Decentralization (Close2HER)

NCT07527741 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT07527741
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07527741 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-World Research of Treatment Patterns and Treatment Adherence in Early HER2-positive Breast Cancer in Serbia After Treatment Decentralization (Close2HER)
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Recruiting
Start date
February 23, 2026
Completion date
October 31, 2028
Enrollment
100 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

early-stage her2+ breast cancer